Brain Aneurysm Treatment Market Overview
Brain aneurysm is an abnormal bulge in the blood vessels of the brain that can go on to cause severe health-based issues and possible even death. It causes the inner muscular layer of the blood vessel wall to weaken. After a prolonged period of time, the blood flow within the artery keeps pushing the thin wall portion and eventually ends-up rupturing it. The bleeding caused due to the ruptured brain artery is known as subarachnoid hemorrhage (SAH). The hemorrhage is so severe that it can lead to stroke, coma, or even death. Various factors contribute to its occurrence, including injury or trauma, cigarette smoking, blood infections, and others. Individuals suffering from this condition of brain aneurysm can be diagnoses through multiple means or techniques, including cerebral angiogram, Computed Tomography (CT) scan, Magnetic Resonance Angiography (MRA), Computed Tomography Angiogram (CTA) scan, and many others. The global brain aneurysm treatment market is expected to grow at a compound annual rate of 13.5% during the forecast period between 2022 and 2030.
A number of factors such as, increasing prevalence of brain aneurysms, advancement in surgical techniques, rising occurrence of high blood pressure, and increasing healthcare funding by government bodies are propelling the growth of brain aneurysm treatment market. Presence of brain aneurysm in the family history are also fuelling up the market to a great extent. According to the Brain Aneurysm Foundation, occurrence of familial aneurysms among subarachnoid hemorrhage patients is 6% to 20%. Despite these drivers, there are some issues associated with brain aneurysm treatment market. High cost of management for aneurysmal subarachnoid hemorrhage, and unknown symptoms of unruptured brain aneurysm may hinder the growth of market to an extent. Brain Aneurysm Foundation states that Brain aneurysms are mostly prevalent at the age of 35 – 60 years whereas aneurysmal hemorrhagic stroke is more common in people aged 50 years.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/4561
Market Research Future (MRFR) asserts in its report that the global Brain Aneurysm Treatment Market is influenced by various key factors. This includes, the increasing and widespread prevalence of brain aneurysms, rising occurrence of high blood pressure, rapid advancements in surgical techniques, and increasing funding by the government and related bodies in the healthcare sector. Also, the presence of brain aneurysm in the family is another key driver of the market. However, issues like high management cost of aneurysmal subarachnoid hemorrhage and unknown symptoms of unruptured brain aneurysm can hamper the overall growth of the market.
Regional Analysis
The Middle East & Africa regions holds the least share in the brain aneurysm treatment market owing to the lack of proper availability of medical facilities. However, the decent growth market in this region is driven by some of the most advancing countries in the Middle East, including Saudi Arabia, the UAE, and Kuwait. While, the African region is expected to garner moderate growth rate.
The global brain aneurysm treatment market is geographically segmented into major regions like Asia Pacific, Europe, the Americas, and the Middle East & Africa.
The Americas hold the dominant share of the global aneurysm treatment market and is expected to grow significantly in the forthcoming years. The growth of the region is attributed to the increasing prevalence of brain aneurysm.
The European region holds the second largest share of the market for brain aneurysm. The region’s growth is proliferated by the support provided by the government for research and development and for the improvement of reimbursement policies in healthcare. Also, cerebrovascular conditions are also seemingly prevalent in this region, which is also aiding the growth herein.
The Asia Pacific region is positioned as one of the key players in the global brain aneurysm treatment landscape. It is expected to hold the potential to be the fastest growing region among the mentioned names. The surging growth and expansion of the region can be owed to the massive patient population and the ameliorating healthcare technology.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/brain-aneurysm-treatment-market-4561
Segments
- By condition, the market divides into ruptured and unruptured aneurysm.
- The brain aneurysm treatment market segmentation is based in terms of condition, type, and end-user.
- By type, the market divides into medication and surgery.
- The surgery segment narrows down further into endovascular coiling, surgical clipping, flow diverter, and others. The flow diverter segment breaks down into silk flow diverter (SILK), pipeline embolization device, and surpass flow diverter (SURPASS).
- The medication segment comprises calcium channel blockers, anti-seizure medications, antacids, antiemetics, analgesics, antihypertensives, stool softeners, and others.
- By end-user, the market includes clinics, hospital, and others.
Brain Aneurysm Treatment Market Players
- Stryker
- Braun Melsungen AG
- MicroPort Scientific Corporation
- Medtronic
- Terumo Corporation
- Integra LifeSciences Corporation
- Johnson & Johnson
- RAUMEDIC AG
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: [email protected]
Brain Aneurysm Treatment Market, Brain Aneurysm Treatment Market size, Brain Aneurysm Treatment Market share, Brain Aneurysm Treatment Market trends, Brain Aneurysm Treatment Market analysis, Brain Aneurysm Treatment Market forecast, Brain Aneurysm Treatment Market demand
Brain aneurysm is also known as cerebral aneurysm or intracranial aneurysm.
Aneurysm has the potential to rupture, which causes bleeding in the surrounding sub-arachnoid space, generally resulting in brain damage or stroke.
Key causes of brain aneurysm include heredity, aging, atherosclerosis infection, and brain injury.Read Report Overview - https://www.transparencymarketresearch.com/brain-aneurysm-treatment-market.html Ruptured brain aneurysm is a critical condition and in a few cases, it could be fatal.
It is generally diagnosed with the help of magnetic resonance angiography, cerebral angiography, or computed tomography (CT) scan.
It is mostly prevalent in adults aged 35–60 years.
On the other hand, high cost of the treatment and unrecognized symptoms of the brain aneurysm are considered to be major restraining factors for the market.Based on treatment type, the brain aneurysm treatment market has been segmented into medication and surgery.
Market HighlightsBrain Aneurysm is an abnormal dilation of arteries in the brain which finally results in the weakening of inner muscular layer of the blood vessel wall.
The resultant bleeding due to ruptured artery in the brain is called subarachnoid hemorrhage (SAH).
Individuals harboring a brain aneurysm can be diagnosed by various techniques, such as Computed Tomography (CT) scan, Computed Tomography Angiogram (CTA) scan, Magnetic Resonance Angiography (MRA), cerebral angiogram, and many others.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/4561A number of factors such as, increasing prevalence of brain aneurysms, advancement in surgical techniques, rising occurrence of high blood pressure, and increasing healthcare funding by government bodies are propelling the growth of brain aneurysm treatment market.
According to the Brain Aneurysm Foundation, occurrence of familial aneurysms among subarachnoid hemorrhage patients is 6% to 20%.
Despite these drivers, there are some issues associated with brain aneurysm treatment market.Regional AnalysisThe Americas dominates the brain aneurysm treatment market owing to the increasing prevalence of brain aneurysm.
According to the 2017 study published in Surg Neurol Int., it is found that more than 3% population of the United States i.e.
Brain Aneurysm Treatment Market Information: By Type (Surgery (Surgical Clipping, Endovascular Coiling), Medication (Antacid, Stool Softener)), Condition (Unruptured Aneurysm, Ruptured Aneurysm), End User (Hospitals, Clinics) - Global Forecast till 2027Market HighlightsBrain Aneurysm is an abnormal dilation of arteries in the brain which finally results in the weakening of inner muscular layer of the blood vessel wall.
Over time, blood flow within the artery starts pushing the thin portion of the wall and ruptures it.
Individuals harboring a brain aneurysm can be diagnosed by various techniques, such as Computed Tomography (CT) scan, Computed Tomography Angiogram (CTA) scan, Magnetic Resonance Angiography (MRA), cerebral angiogram, and many others.A number of factors such as, increasing prevalence of brain aneurysms, advancement in surgical techniques, rising occurrence of high blood pressure, and increasing healthcare funding by government bodies are propelling the growth of brain aneurysm treatment market.
Despite these drivers, there are some issues associated with brain aneurysm treatment market.
Regional AnalysisThe Americas dominates the brain aneurysm treatment market owing to the increasing prevalence of brain aneurysm.
It is also estimated that nearly 1.6 million individuals in Germany are suffering from Unruptured intracranial aneurysms (UIAs).Asia Pacific is the fastest growing brain aneurysm treatment market owing to the huge patient population and developing healthcare technology.The Middle East & Africa holds the least share of brain aneurysm treatment market due to limited availability of medical facilities.
Brain Aneurysm Treatment Market OverviewBrain aneurysm is an abnormal bulge in the blood vessels of the brain that can go on to cause severe health-based issues and possible even death.
The bleeding caused due to the ruptured brain artery is known as subarachnoid hemorrhage (SAH).
Individuals suffering from this condition of brain aneurysm can be diagnoses through multiple means or techniques, including cerebral angiogram, Computed Tomography (CT) scan, Magnetic Resonance Angiography (MRA), Computed Tomography Angiogram (CTA) scan, and many others.
The global brain aneurysm treatment market size is expected to grow at a compound annual rate of 5.4% during the forecast period between 2017 and 2023.Market Research Future (MRFR) asserts in its report that the global market is influenced by various key factors.
This includes, the increasing and widespread prevalence of brain aneurysms, rising occurrence of high blood pressure, rapid advancements in surgical techniques, and increasing funding by the government and related bodies in the healthcare sector.
Also, the presence of brain aneurysm in the family is another key driver of the market.However, issues like high management cost of aneurysmal subarachnoid hemorrhage and unknown symptoms of unruptured brain aneurysm can hamper the overall growth of the market.Brain Aneurysm Treatment Market SegmentationThe brain aneurysm treatment market segmentation is based in terms of condition, type, and end-user.By type, the market divides into medication and surgery.The surgery segment narrows down further into endovascular coiling, surgical clipping, flow diverter, and others.
